Quarterly Transactions Made in Ligand Pharmaceuticals Inc (LGND)
This table provides information about the institutional ownership of Ligand Pharmaceuticals Inc (LGND). The information is specifically focused on institutions that hold shares of LIGAND PHARMACEUTICALS INC.
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 1,628,637 | 597,972 | 2,226,609 | 909,922 | 607,430 | 1,517,352 | 709,257 | |
Q4 2021 | 329,815 | 360,726 | 690,541 | 502,434 | 121,844 | 624,278 | 66,263 | |
Q1 2022 | 742,091 | 115,957 | 858,048 | 981,317 | 648,766 | 1,630,083 | -772,035 | |
Q2 2022 | 480,727 | 386,063 | 866,790 | 1,132,038 | 223,973 | 1,356,011 | -489,221 | |
Q3 2022 | 460,934 | 354,236 | 815,170 | 652,729 | 7,179 | 659,908 | 155,262 | |
Q4 2022 | 982,039 | 677,972 | 1,660,011 | 1,092,760 | 0 | 1,092,760 | 567,251 | |
Q1 2023 | 662,870 | 684,251 | 1,347,121 | 710,170 | 324 | 710,494 | 636,627 | |
Q2 2023 | 1,064,064 | 274,200 | 1,338,264 | 341,242 | 121,773 | 463,015 | 875,249 | |
Q3 2023 | 735,153 | 407,248 | 1,142,401 | 534,741 | 127,267 | 662,008 | 480,393 | |
Q4 2023 | 964,886 | 263,723 | 1,228,609 | 516,633 | 0 | 516,633 | 711,976 | |
Q1 2024 | 1,225,230 | 586,426 | 1,811,656 | 774,346 | 0 | 774,346 | 1,037,310 | |
Q2 2024 | 984,326 | 1,447,324 | 2,431,650 | 1,129,529 | 0 | 1,129,529 | 1,302,121 | |
Q3 2024 | 906,763 | 546,094 | 1,452,857 | 353,861 | 0 | 353,861 | 1,098,996 |